Concepedia

Joanna Vitfell-Rasmussen

JV

6

Publications

455

Citations

6

H-Index

2014

Active since

Affiliations

Institute of Cancer Research(Current)

Herlev Hospital

Royal Marsden NHS Foundation Trust

Royal Marsden Hospital

Joanna Vitfell-Rasmussen is an author at Institute of Cancer Research specializing in cancer research, radiation oncology, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2014–2022

6

Publications

6

Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors

L. Rhoda Molife, Yan Li, Joanna Vitfell-Rasmussen et al. · Journal of Hematology & Oncology · 2014 · 189 citations · Full text

89Zr-trastuzumab and 89Zr-bevacizumab PET to Evaluate the Effect of the HSP90 Inhibitor NVP-AUY922 in Metastatic Breast Cancer Patients

Sietske B.M. Gaykema, Carolien P. Schröder, Joanna Vitfell-Rasmussen et al. · Clinical Cancer Research · 2014 · 114 citations

A retrospective study of patients with malignant PEComa receiving treatment with sirolimus or temsirolimus: the Royal Marsden Hospital experience.

Charlotte Benson, Joanna Vitfell-Rasmussen, Marco Maruzzo et al. · PubMed · 2014 · 81 citations

A Phase I/II Clinical Trial of Belinostat (PXD101) in Combination with Doxorubicin in Patients with Soft Tissue Sarcomas

Joanna Vitfell-Rasmussen, Ian Judson, Akmal Safwat et al. · Sarcoma · 2016 · 31 citations · Full text

, , +13

Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours

Robin L. Jones, Mark J. Ratain, Peter J. O’Dwyer et al. · European Journal of Cancer · 2019 · 28 citations · Full text

Rows per page

1–5 of 6